We are live on
!
Find out more
LSV Asset Management Portfolio holdings
AUM
$55.1B
1-Year Est. Return
45.38%
This Fund
S&P 500
This Quarter
Est. Return
-1.94%
1 Year Est. Return
+45.38%
3 Year Est. Return
+99.45%
5 Year Est. Return
+122.42%
10 Year Est. Return
+379.58%
AUM
$55.3B
AUM Growth
-$3.5B
(-5.9%)
Cap. Flow
-$1.95B
Cap. Flow
% of AUM
-3.53%
Top 10 Holdings %
Top 10 Hldgs %
14.44%
Holding
951
New
37
Increased
176
Reduced
438
Closed
47
Avg Time Held
18.3
quarters
Top 10 Avg Time Held
11.1
quarters
Top 20 Avg Time Held
14.5
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qorvo
QRVO
|
+$166M |
| 2 |
Fox Class A
FOXA
|
+$160M |
| 3 |
ExxonMobil
XOM
|
+$95.5M |
| 4 |
Intel
INTC
|
+$80.6M |
| 5 |
Murphy USA
MUSA
|
+$75.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$314M |
| 2 |
HCA Healthcare
HCA
|
+$229M |
| 3 |
VER
VEREIT, Inc.
VER
|
+$154M |
| 4 |
Exelon
EXC
|
+$138M |
| 5 |
Textron
TXT
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.29% |
| 2 | Technology | 14.59% |
| 3 | Healthcare | 14.23% |
| 4 | Consumer Discretionary | 12.76% |
| 5 | Industrials | 10.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Intel
INTC
$542B
| $1.12B | 2.03% |
21,095,429
+1,486,598
| +8% | +$80.6M |
2013 Q2
33 quarters
|
|
2
Merck
MRK
$353B
| $1.1B | 1.99% |
14,685,772
+379,681
| +3% | +$28.9M |
2013 Q2
33 quarters
|
|
3
Pfizer
PFE
$161B
| $948M | 1.71% |
22,034,548
+195,996
| +0.9% | +$8.68M |
2013 Q2
33 quarters
|
|
4
Verizon
VZ
$180B
| $883M | 1.6% |
16,348,930
-623,333
| -4% | -$34.5M |
2013 Q2
33 quarters
|
|
5
Oracle
ORCL
$432B
| $869M | 1.57% |
9,968,320
-463,293
| -4% | -$40.9M |
2013 Q2
33 quarters
|
|
6
Citigroup
C
$214B
| $666M | 1.2% |
9,494,132
-398,650
| -4% | -$27.9M |
2013 Q2
33 quarters
|
|
7
Kroger
KR
$36.1B
| $625M | 1.13% |
15,459,158
-491,691
| -3% | -$20.6M |
2013 Q2
33 quarters
|
|
8
Bristol-Myers Squibb
BMY
$116B
| $620M | 1.12% |
10,473,489
-171,154
| -2% | -$11.3M |
2018 Q2
13 quarters
|
|
9
eBay
EBAY
$51.6B
| $579M | 1.05% |
8,310,948
-934,940
| -10% | -$67M |
2015 Q3
24 quarters
|
|
10
AT&T
T
$157B
| $574M | 1.04% |
28,124,188
-954,280
| -3% | -$20M |
2013 Q2
33 quarters
|
|
11
Allstate
ALL
$59.6B
| $554M | 1% |
4,352,708
-127,852
| -3% | -$16.9M |
2013 Q2
33 quarters
|
|
12
Target
TGT
$69.4B
| $543M | 0.98% |
2,372,177
-241,452
| -9% | -$60.5M |
2013 Q2
33 quarters
|
|
13
Ameriprise Financial
AMP
$43.6B
| $539M | 0.97% |
2,039,577
-185,097
| -8% | -$48.4M |
2013 Q2
33 quarters
|
|
14
CVS Health
CVS
$112B
| $525M | 0.95% |
6,181,212
-198,547
| -3% | -$16.6M |
2013 Q2
33 quarters
|
|
15
Amgen
AMGN
$225B
| $504M | 0.91% |
2,371,418
-20,225
| -0.8% | -$4.66M |
2013 Q2
33 quarters
|
|
16
Cisco
CSCO
$454B
| $493M | 0.89% |
9,061,629
-682,200
| -7% | -$38.3M |
2013 Q2
33 quarters
|
|
17
Seagate
STX
$168B
| $483M | 0.87% |
5,851,912
-176,440
| -3% | -$15.4M |
2013 Q2
33 quarters
|
|
18
Morgan Stanley
MS
$296B
| $477M | 0.86% |
4,903,333
-256,867
| -5% | -$25.5M |
2013 Q2
33 quarters
|
|
19
Cummins
CMI
$72.2B
| $472M | 0.85% |
2,101,229
+109,970
| +6% | +$25.8M |
2014 Q3
28 quarters
|
|
20
Comcast
CMCSA
$73.9B
| $454M | 0.82% |
8,117,243
-1,259,825
| -13% | -$73.5M |
2013 Q2
33 quarters
|
|
21
IBM
IBM
$218B
| $446M | 0.81% |
3,356,942
+55,772
| +2% | +$7.46M |
2013 Q2
33 quarters
|
|
22
Citizens Financial Group
CFG
$26.6B
| $421M | 0.76% |
8,963,299
-258,081
| -3% | -$11.3M |
2016 Q3
20 quarters
|
|
23
J.M. Smucker
SJM
$13B
| $417M | 0.75% |
3,470,705
-26,005
| -0.7% | -$3.31M |
2017 Q3
16 quarters
|
|
24
Whirlpool
WHR
$1.9B
| $414M | 0.75% |
2,029,938
+68,279
| +3% | +$15M |
2013 Q2
33 quarters
|
|
25
HP
HPQ
$27.6B
| $411M | 0.74% |
15,037,176
-344,724
| -2% | -$9.9M |
2013 Q2
33 quarters
|
|
Similar funds
HF
LSV Asset Management's Q3 2021 Portfolio in Review
As of Q3 2021, LSV Asset Management held 951 positions worth $55.3B, down 5.9% from $58.8B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
LSV Asset Management withdrew a net $1.95B in Q3 2021, closing 47 positions and reducing 438 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $314M position sold in full.
By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.
Against the trend, LSV Asset Management opened a new position in Ryder worth $24.7M.
- LSV Asset Management's largest Q3 2021 buy was Ryder: 298,150 shares worth $24.7M.
- LSV Asset Management added most to Qorvo in Q3 2021, an estimated $166M increase.
- LSV Asset Management's biggest Q3 2021 reduction was HCA Healthcare, cutting an estimated $229M.
- LSV Asset Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $314M.
- LSV Asset Management's ten largest holdings make up 14% of its $55.3B portfolio in Q3 2021.
- LSV Asset Management opened 37 new positions and closed 47 in Q3 2021.
- LSV Asset Management's portfolio value fell 5.9% quarter-over-quarter to $55.3B.
Based on LSV Asset Management's 13F filing for Q3 2021, filed 4 Nov 2021.